Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer.
Journal: JAMA oncology
Published: December 02, 2017
Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 13, 2017
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
Journal: JAMA
Published: December 29, 2016
Showing 1-5 of 5
Last Updated: 09/26/2026